A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period

---
identifier: "/us/fr/2015-28456"
source: "fr"
legal_status: "authoritative_unofficial"
title: "A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period"
title_number: 0
title_name: "Federal Register"
section_number: "2015-28456"
section_name: "A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period"
positive_law: false
currency: "2015-11-09"
last_updated: "2015-11-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2015-28456"
document_type: "notice"
publication_date: "2015-11-09"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "80 FR 69226"
fr_volume: 80
docket_ids:
  - "Docket Number CDC-2015-0075"
  - "NIOSH-288"
comments_close_date: "2016-03-08"
fr_action: "Notice and extension of comment period."
---


#  A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period

**AGENCY:**

National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION:**

Notice and extension of comment period.

**SUMMARY:**

On September 8, 2015, the Director of the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the *Federal Register* [80 FR 53802] announcing the availability of the following draft document for public comment entitled *A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs.* Written comments  were to be received by November 9, 2015. NIOSH is extending the public comment period for an additional 120 days.

**DATES:**

NIOSH is extending the comment period on the document published September 8, 2015 (80 FR 53802). Electronic or written comments must be received by March 8, 2016.

**ADDRESSES:**

You may submit comments, identified by CDC-2015-0075 and docket number NIOSH-288, by any of the following methods:

• *Federal eRulemaking Portal: www.regulations.gov* —Follow the instructions for submitting comments.

• *Mail* : National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998.

**FOR FURTHER INFORMATION CONTACT:**

Deborah V. Hirst, NIOSH, Division of Applied Research and Technology, Alice Hamilton Laboratories, 1090 Tusculum Avenue, MS R-5, Cincinnati, Ohio 45226, telephone (513) 841-4141 (not a toll free number), Email: *[email protected].*

Dated: November 2, 2015.

John Howard,

Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.